Standard

Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. / Lopatin, Denis A.; Ailamazian, Eduard K.; Dmitrieva, Renata I.; Shpen, Vladimir M.; Fedorova, Olga V.; Doris, Peter A.; Bagrov, Alexei Y.

In: Journal of Hypertension, Vol. 17, No. 8, 1999, p. 1179-1187.

Research output: Contribution to journalArticlepeer-review

Harvard

Lopatin, DA, Ailamazian, EK, Dmitrieva, RI, Shpen, VM, Fedorova, OV, Doris, PA & Bagrov, AY 1999, 'Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia', Journal of Hypertension, vol. 17, no. 8, pp. 1179-1187. https://doi.org/10.1097/00004872-199917080-00018

APA

Lopatin, D. A., Ailamazian, E. K., Dmitrieva, R. I., Shpen, V. M., Fedorova, O. V., Doris, P. A., & Bagrov, A. Y. (1999). Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. Journal of Hypertension, 17(8), 1179-1187. https://doi.org/10.1097/00004872-199917080-00018

Vancouver

Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA et al. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. Journal of Hypertension. 1999;17(8):1179-1187. https://doi.org/10.1097/00004872-199917080-00018

Author

Lopatin, Denis A. ; Ailamazian, Eduard K. ; Dmitrieva, Renata I. ; Shpen, Vladimir M. ; Fedorova, Olga V. ; Doris, Peter A. ; Bagrov, Alexei Y. / Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. In: Journal of Hypertension. 1999 ; Vol. 17, No. 8. pp. 1179-1187.

BibTeX

@article{216c434bae8d4666acee0e9480a39d3c,
title = "Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia",
abstract = "Objective. To determine plasma levels of the endogenous bufodienolide Na+/K+ ATPase inhibitor, marinobufagenin-like factor (MBG), in normotensive pregnancy and in preeclampsia, to compare changes of MBG with that of ouabain-like compound (OLC), and to characterize the purified MBG immunoreactive factor from preeclamptic plasma. Design and methods. Consecutive sample study. The levels of MBG and OLC compounds were measured in extracted plasma by solid phase fluoroimmunoassays. MBG and ouabain immunoreactive materials were partially purified from preeclamptic plasma via reverse-phase high-performance liquid chromatography (HPLC) and studied for their ability to cross react with MBG and ouabain antibodies, and to inhibit the Na+/K+ ATPase from human mesenteric arteries. Vasoconstrictor effect of authentic MBG was studied in isolated rings of human umbilical arteries. Results. In 11 nonpregnant control individuals, plasma concentrations of MBG and OLC were 0.190 ± 0.04 nmol/l and 0.297 ± 0.037 nmol/l, respectively. In the third trimester of noncomplicated pregnancy (n = 6), plasma MBG increased (0.625 ± 0.067 nmol/l, P < 0.05), and OLC did not (0.32 ± 0.07 nmol/l). In 15 patients with preeclampsia, plasma levels of both MBG and OLC increased dramatically (2.63 ± 0.10 nmol/l and 0.697 ± 0.16 nmol/l, respectively P < 0.01 versus both control groups). When fractionated by reverse phase HPLC, OLC was eluted by 18% acetonitrile, and MBG by 48% acetonitrile. Serially diluted samples of MBG and OLC immunoreactive materials from HPLC fractions reacted with MBG and ouabain antibody in solid phase immunoassay in a concentration dependent fashion. Authentic MBG caused contractile responses of isolated rings of human mesenteric arteries in a concentration-dependent manner. Similarly to the authentic MBG, HPLC purified MBG immunoreactive material from preeclamptic plasma inhibited Na+/K+ ATPase purified from human mesenteric artery. Conclusions. Our observations demonstrate the coexistence of two endogenous cardiotonic steroids in preeclamptic plasma, a more polar OLC and a less polar MBG-like compound. Substantial increases in plasma OLC and MBG immunoreactivity in preeclampsia, along with the vasoconstrictor properties of authentic MBG and Na+/K+ ATPase inhibitory activity of human MBG immunoreactive factor, suggest, that in preeclampsia, plasma concentrations of MBG are enough to substantially inhibit the sodium pump in cardiovascular tissues, and are in accordance with the views attributing endogenous digitalis-like factors a pathogenic role in the preeclamptic hypertension.",
keywords = "Bufadienodide, High-performance liquid chromatography, Hypertension, Na/K ATPase, Ouabain, Preeclampsia, Pregnancy, Umbilical artery",
author = "Lopatin, {Denis A.} and Ailamazian, {Eduard K.} and Dmitrieva, {Renata I.} and Shpen, {Vladimir M.} and Fedorova, {Olga V.} and Doris, {Peter A.} and Bagrov, {Alexei Y.}",
year = "1999",
doi = "10.1097/00004872-199917080-00018",
language = "English",
volume = "17",
pages = "1179--1187",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

RIS

TY - JOUR

T1 - Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia

AU - Lopatin, Denis A.

AU - Ailamazian, Eduard K.

AU - Dmitrieva, Renata I.

AU - Shpen, Vladimir M.

AU - Fedorova, Olga V.

AU - Doris, Peter A.

AU - Bagrov, Alexei Y.

PY - 1999

Y1 - 1999

N2 - Objective. To determine plasma levels of the endogenous bufodienolide Na+/K+ ATPase inhibitor, marinobufagenin-like factor (MBG), in normotensive pregnancy and in preeclampsia, to compare changes of MBG with that of ouabain-like compound (OLC), and to characterize the purified MBG immunoreactive factor from preeclamptic plasma. Design and methods. Consecutive sample study. The levels of MBG and OLC compounds were measured in extracted plasma by solid phase fluoroimmunoassays. MBG and ouabain immunoreactive materials were partially purified from preeclamptic plasma via reverse-phase high-performance liquid chromatography (HPLC) and studied for their ability to cross react with MBG and ouabain antibodies, and to inhibit the Na+/K+ ATPase from human mesenteric arteries. Vasoconstrictor effect of authentic MBG was studied in isolated rings of human umbilical arteries. Results. In 11 nonpregnant control individuals, plasma concentrations of MBG and OLC were 0.190 ± 0.04 nmol/l and 0.297 ± 0.037 nmol/l, respectively. In the third trimester of noncomplicated pregnancy (n = 6), plasma MBG increased (0.625 ± 0.067 nmol/l, P < 0.05), and OLC did not (0.32 ± 0.07 nmol/l). In 15 patients with preeclampsia, plasma levels of both MBG and OLC increased dramatically (2.63 ± 0.10 nmol/l and 0.697 ± 0.16 nmol/l, respectively P < 0.01 versus both control groups). When fractionated by reverse phase HPLC, OLC was eluted by 18% acetonitrile, and MBG by 48% acetonitrile. Serially diluted samples of MBG and OLC immunoreactive materials from HPLC fractions reacted with MBG and ouabain antibody in solid phase immunoassay in a concentration dependent fashion. Authentic MBG caused contractile responses of isolated rings of human mesenteric arteries in a concentration-dependent manner. Similarly to the authentic MBG, HPLC purified MBG immunoreactive material from preeclamptic plasma inhibited Na+/K+ ATPase purified from human mesenteric artery. Conclusions. Our observations demonstrate the coexistence of two endogenous cardiotonic steroids in preeclamptic plasma, a more polar OLC and a less polar MBG-like compound. Substantial increases in plasma OLC and MBG immunoreactivity in preeclampsia, along with the vasoconstrictor properties of authentic MBG and Na+/K+ ATPase inhibitory activity of human MBG immunoreactive factor, suggest, that in preeclampsia, plasma concentrations of MBG are enough to substantially inhibit the sodium pump in cardiovascular tissues, and are in accordance with the views attributing endogenous digitalis-like factors a pathogenic role in the preeclamptic hypertension.

AB - Objective. To determine plasma levels of the endogenous bufodienolide Na+/K+ ATPase inhibitor, marinobufagenin-like factor (MBG), in normotensive pregnancy and in preeclampsia, to compare changes of MBG with that of ouabain-like compound (OLC), and to characterize the purified MBG immunoreactive factor from preeclamptic plasma. Design and methods. Consecutive sample study. The levels of MBG and OLC compounds were measured in extracted plasma by solid phase fluoroimmunoassays. MBG and ouabain immunoreactive materials were partially purified from preeclamptic plasma via reverse-phase high-performance liquid chromatography (HPLC) and studied for their ability to cross react with MBG and ouabain antibodies, and to inhibit the Na+/K+ ATPase from human mesenteric arteries. Vasoconstrictor effect of authentic MBG was studied in isolated rings of human umbilical arteries. Results. In 11 nonpregnant control individuals, plasma concentrations of MBG and OLC were 0.190 ± 0.04 nmol/l and 0.297 ± 0.037 nmol/l, respectively. In the third trimester of noncomplicated pregnancy (n = 6), plasma MBG increased (0.625 ± 0.067 nmol/l, P < 0.05), and OLC did not (0.32 ± 0.07 nmol/l). In 15 patients with preeclampsia, plasma levels of both MBG and OLC increased dramatically (2.63 ± 0.10 nmol/l and 0.697 ± 0.16 nmol/l, respectively P < 0.01 versus both control groups). When fractionated by reverse phase HPLC, OLC was eluted by 18% acetonitrile, and MBG by 48% acetonitrile. Serially diluted samples of MBG and OLC immunoreactive materials from HPLC fractions reacted with MBG and ouabain antibody in solid phase immunoassay in a concentration dependent fashion. Authentic MBG caused contractile responses of isolated rings of human mesenteric arteries in a concentration-dependent manner. Similarly to the authentic MBG, HPLC purified MBG immunoreactive material from preeclamptic plasma inhibited Na+/K+ ATPase purified from human mesenteric artery. Conclusions. Our observations demonstrate the coexistence of two endogenous cardiotonic steroids in preeclamptic plasma, a more polar OLC and a less polar MBG-like compound. Substantial increases in plasma OLC and MBG immunoreactivity in preeclampsia, along with the vasoconstrictor properties of authentic MBG and Na+/K+ ATPase inhibitory activity of human MBG immunoreactive factor, suggest, that in preeclampsia, plasma concentrations of MBG are enough to substantially inhibit the sodium pump in cardiovascular tissues, and are in accordance with the views attributing endogenous digitalis-like factors a pathogenic role in the preeclamptic hypertension.

KW - Bufadienodide

KW - High-performance liquid chromatography

KW - Hypertension

KW - Na/K ATPase

KW - Ouabain

KW - Preeclampsia

KW - Pregnancy

KW - Umbilical artery

UR - http://www.scopus.com/inward/record.url?scp=0032785463&partnerID=8YFLogxK

U2 - 10.1097/00004872-199917080-00018

DO - 10.1097/00004872-199917080-00018

M3 - Article

C2 - 10466474

AN - SCOPUS:0032785463

VL - 17

SP - 1179

EP - 1187

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 8

ER -

ID: 87788148